Recent investigations suggest that activation of Th17 cells and/or deficiency of regulatory T cells (Treg), as these are two major types of CCL20-responsive cell types, is involved in the pathogenesis of IBD [4, 5, 15]. This evidence concerns the gene CCL20 and inflammatory bowel disease.